Adjuvant chemotherapy in soft tissue sarcomas in adults;Chimiotherapie adjuvante des sarcomes des tissus mous

Cancer/Radiotherapie

Volumn 1, Issue 5, 1997, Pages 462-466

  Levy E ^a   Thirion, P ^a   Piedbois, P ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Adjuvant; Chemotherapy; Sarcoma; Soft tissue neoplasms

Indexed keywords

DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; CANCER GRADING; CANCER SURVIVAL; CONFERENCE PAPER; CONSERVATIVE TREATMENT; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; CANCER STAGING; FOLLOW UP; PATHOLOGY; PROGNOSIS; REVIEW; SARCOMA; SOFT TISSUE TUMOR; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DACARBAZINE; DOXORUBICIN; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; NEOPLASM STAGING; PROGNOSIS; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0344589322     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(97)89578-9     Document Type: Conference Paper

References (36)

1. Alvegard TA, Sigurdsson H, Mouridsen H, Solheim O, Unsgaard B, Ringborg U et al. Adjuvant chemotherapy with doxorubicin in high grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol 1989;7: 1504-13
2. Amman K, Suit H, Amato D, Corson J, Wood W, Proppe K et al. Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment group. J Clin Oncol 1984;2:601-8
3. Baker LH, Frank J, Fine G, Balcerzak S, Fletcher WS, Stephens RL et al. Combination chemotherapy using adriamycin, DTIC, cyclophosphamide and actinomycin D for advanced soft tissue sarcoma: a randomized comparative trial. ] Clin Oncol 1987;5:851-61
4. Balcerzak SP, Benedetti J, Weiss GR, Natale RB. A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A Southwest Oncology Group Study. Cancer 1995;76: 2248-52
5. Bell RS, O'Sullivan B, Liu FF, Power J, Langer F, Fornasier VL et al. The surgical margin in soft tissue sarcoma. J Bone Jt Surg 1989:71:370-5
6. Benjamin RS, Terjanian TO, Fenoglio C, Barkley HT, Evans HL, Murphy WK et al. The importance of combination chemotherapy for adjuvant treatment of high-risk patients with soft tissue sarcomas of the extremities. In: Salmon SE, ed. Adjuvant Therapy of Cancer. Volume V. Orlando: Grune and Station, 1987: 735-44
7. Bramwell VH, Eisenhauer EA, Blackstein M, Boos G, Knowling M, Jolivet J et al. Phase II study of topotecan (NSC 609 699) in patients with recurrent or metastatic soft tissue sarcoma. Ann Oncol 1995;6:847-9
8. Bramwell VH, Mouridsen HT, Santoro A, Blackledge G, Somers R, Verweij J et al. Cyclophosphamide versus ifosfamide. A randomized phase II trial in adult soft tissue sarcoma: The European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcomas Group. Cancer Chem Pharmacol 1993;31(suppl 2):S180
9. Bramwell V, Rouesse J, Steward W, Santoro A, SchraffordtKoops H, Buesa J et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma. Reduced local recurrence but no improvement in survival: a study of the European Oranization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994; 12:1137-49
10. Cany L, Bui NB, Stöckle E, Coindre JM, Kantor G, Ravaud A. Chimiothérapie d'induction et traitement combiné conservateur des sarcomes des tissus mous de l'adulte. Bull Cancer 1992; 79:1077-85
11. Chang AE, Kinsella T, Glatstein E, Baker AR, Sindelar WF, Lotze MT et al. Adjuvant chemotherapy for patients with high grade soft tissue sarcomas of the extremity. J Clin Oncol 1988; 6:1491-500
12. Edmonson JH, Fleming TR, Ivins JC, Burgert EO Jr, Soule EH, Pritchard DJ et al. Randomized study of systemic chemotherapy following complete excision of non osseous sarcoma. J Clin Oncol 1984;2:1390-6
13. Edmonson JH, Ryan L, Blum RH, Brooks JS, Shiraki M, Frytak S. Randomized comparison of doxorubicin alone vs ifosfa-niide plus doxorubicin or mitomycin, doxorubicin and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 1993;11: 1269-75
14. E,ilber FR, Giuliano AE, Huth JF, Morton DL. Postoperative adjuvant chemotherapy (adriamycin) in high grade extremity soft tissue sarcoma : a randomized prospective trial. In: Salmon SE, ed. Adjuvant Therapy of Cancer. Volume V. Orlando: Grune and Stratton, 1987:719-24
15. Gaynor JJ, Tan CC, Casper ES, Collin CF, Friedrich C, Shiu M et al. Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults. J Clin Onco/1992:10:1317-29
16. Gherlinzoni F, Picci P, Bacci G, de Cristofaro R, Cazzola A, Zmerly H et al. Late results of a randomized trial for the treatment of soft tissue sarcomas (STS) of the extremities in adults patients [Abstract]. Proc ASCO, 1993:12
17. Gian V, Lynch J, MacCarley D. Taxol in the treatment of recurrent or metastatic soft tissue or osteosarcomas [Abstract]. Proc ASCO 1995;14:516
18. Glenn J, Kinsella J, Glatstein E, Tepper J, Baker AR, Sindelar WF et al. A randomized prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast and trunk. Cancer 1985;55:1206-14
19. Glenn J, Sindelar W, Kinsella T. Results of multimodality therapy of resectable sarcomas of the retroperitoneum. Surgery 1985;97:316
20. Heise NW, Myers MH, Russel WO, Suit HD, Enzinger FM, Edmonson JH et al. Recurrence free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer 1986;57:172-7
21. Herbert SH, Corn BW, Solin LJ, Lanciano RM, Schultz DJ, McKenna WG et al. Limb preserving treatment for soft tissue Siircomas of the extremities. The significance of surgical margins. Cancer 1993:72:1230-8
22. Karakoussis CP, Emrich LJ, Rao U, Krishnamsetty RM. Feasibility of limb salvage and survival in soft tissue sarcoma. Cancf.r 1986:57:484-91
23. Lerner HJ, Amato DA, Savlov ED, DeWys WD, Mittelman A, Lrtasun RC et al. Eastern Cooperative Oncology Group: a comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma. J Clin Oncol 1987; 5:613-7
24. Levine EA, Trippon M, Das Gupta TK. Preoperative multimodality treatment for soft tissue sarcomas [see comments]. Cancer 1'993:71:3685-9
25. Lindberg RD, Martin RG, Romsdahl MH, Barkley HT Jr. Conservative surgery and postoperative surgery in 300 adults with soft tissue sarcomas. Cancer 1981;47:2391-7
26. Mandard AM, Petiot JF, Marnay J, Mandard JC, Chasle J, de Ranieri E et al. Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer 1989:63:1437-51
27. Markhede G. Angervall L, Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft tissue tumors. Cancer 1982;49:1721-33
28. Pezzi CM, Pollock RE, Evans HL, Lorigan JG, Pezzi TA. Benjamin RS et al. Preoperative chemotherapy for soft tissue sarcomas of the extremities. Arch Surg 1990:21:476-81
29. Omura GA, Blessing JA, Major F, Lifshitz S, Ehrlich CE, Mangan C et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol 1985;3:1240-5
30. Rahoty P, Konya A. Results of preoperative neoadjuvant chemotherapy and surgery in the management of patients with soft tissue sarcoma. Eur J Surg Oncol 1993;19:641-5
31. Ravaud A, Bui MB, Coindre JM, Kantor G, Stöckle E, Lagarde P et al. Adjuvant chemotherapy with CYVADIC in high risk soft tissue sarcoma: a randomized prospective trial. In: Salmon SE, ed. Adjuvant Therapy of Cancer. Volume VI. Philadelphia: WB Saunders, 1990:556-66
32. Ravaud A, Bui NB, Coindre JM, Lagarde P, Tramond P, Boriichon F et al. Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials. Br J Cancer 1992;66:961-9
33. In : Sarcomes des tissus mous et ostéosarcomes : Standards, options et recommandations de la Fédération nationale de centres de lutte contre le cancer. 1995:58-88
34. Schoenfeld D, Rosenbaum C, Horton J, Woher JM, Falkson (3, De Conti RC. A comparison of adriamycin versus vincristine, adriamycin and cyclophosphamide for advanced sarcomas. Cancer 1982;50:2757-62
35. Stotter AT, A'Heru RP, Fisher C, Mott AF, Fallowfield ME, Westburry G et al. The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer 1990; 65:1119-29
36. Van Hoesel QG, Verweij J, Catimel G, Clavel M, Kerbrat P, Van Oosterom AT et al. Phase II study of docetaxel (Taxotere) in advanced soft tissue sarcomas of the adults: EORTC Soft Tissue and Bone Sarcoma Group. Ann Oncol 1994;5: 539-42